GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $777,000 | -74.9% | 18,189 | -76.5% | 0.01% | -76.2% |
| Q2 2019 | $3,098,000 | -4.2% | 77,400 | 0.0% | 0.02% | -12.5% |
| Q1 2019 | $3,234,000 | -14.8% | 77,400 | -22.1% | 0.02% | -29.4% |
| Q4 2018 | $3,795,000 | +29.6% | 99,300 | +36.2% | 0.03% | +54.5% |
| Q3 2018 | $2,928,000 | -0.4% | 72,900 | 0.0% | 0.02% | -45.0% |
| Q2 2018 | $2,939,000 | +3.2% | 72,900 | 0.0% | 0.04% | +8.1% |
| Q1 2018 | $2,848,000 | +147.9% | 72,900 | +125.0% | 0.04% | +146.7% |
| Q4 2017 | $1,149,000 | -67.5% | 32,400 | -62.8% | 0.02% | -76.6% |
| Q3 2017 | $3,535,000 | -5.5% | 87,046 | +0.4% | 0.06% | -1.5% |
| Q2 2017 | $3,739,000 | +87.0% | 86,714 | +82.8% | 0.06% | +75.7% |
| Q1 2017 | $2,000,000 | +2.6% | 47,438 | -6.3% | 0.04% | -15.9% |
| Q4 2016 | $1,950,000 | -10.6% | 50,635 | +0.2% | 0.04% | -2.2% |
| Q3 2016 | $2,180,000 | -8.9% | 50,547 | -8.4% | 0.04% | -27.4% |
| Q2 2016 | $2,392,000 | +9.8% | 55,184 | +2.7% | 0.06% | +5.1% |
| Q1 2016 | $2,178,000 | -2.3% | 53,715 | -2.7% | 0.06% | -20.3% |
| Q4 2015 | $2,229,000 | +16.6% | 55,233 | +11.1% | 0.07% | -5.1% |
| Q3 2015 | $1,911,000 | +82.0% | 49,700 | +97.2% | 0.08% | +129.4% |
| Q2 2015 | $1,050,000 | +230.2% | 25,200 | +265.2% | 0.03% | +209.1% |
| Q1 2015 | $318,000 | -5.9% | 6,900 | -12.7% | 0.01% | -8.3% |
| Q4 2014 | $338,000 | -82.2% | 7,900 | -80.8% | 0.01% | -82.4% |
| Q3 2014 | $1,894,000 | -6.6% | 41,200 | +8.7% | 0.07% | +51.1% |
| Q2 2014 | $2,027,000 | +4.8% | 37,900 | +4.7% | 0.04% | -8.2% |
| Q1 2014 | $1,934,000 | +43.8% | 36,200 | +43.7% | 0.05% | -14.0% |
| Q4 2013 | $1,345,000 | +7.3% | 25,200 | +0.8% | 0.06% | 0.0% |
| Q3 2013 | $1,254,000 | +92.9% | 25,000 | +92.3% | 0.06% | +67.6% |
| Q2 2013 | $650,000 | – | 13,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |